John E. Knox
Revolution Medicines (United States)(US)Cancer Research Center(US)21st Century Technologies (United States)(US)Disco (Germany)(DE)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Cancer Research and Treatments, ATP Synthase and ATPases Research, Mechanisms of cancer metastasis, Crystallization and Solubility Studies
Most-Cited Works
- → Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy(2024)280 cited
- → Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers(2024)241 cited
- → Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS(2023)211 cited
- → Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors(2005)152 cited
- → Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis(2008)99 cited
- → Peptide Inhibitors of West Nile NS3 Protease: SAR Study of Tetrapeptide Aldehyde Inhibitors(2006)85 cited